Organigram Holdings Inc. is an holding company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada.
Company profile
Ticker
OGI
Exchange
Website
CEO
Gregory Engel
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
ORGANIGRAM HOLDINGS INC
SEC CIK
Corporate docs
OGI stock data
Latest filings (excl ownership)
6-K
Phylos is a recognized leader in seed genetics with a growing IP portfolio including the highest potency THCV cultivars available
25 May 23
6-K
Organigram Holdings Inc. 6-K
23 May 23
6-K
Organigram Holdings Inc. 6-K
19 May 23
6-K
Organigram Holdings Inc. 6-K
12 May 23
CT ORDER
Confidential treatment order
3 May 23
6-K
Current report (foreign)
11 Apr 23
6-K
Organigram Holdings Inc. 6-K
4 Apr 23
6-K
Organigram Holdings Inc. 6-K
31 Mar 23
6-K
Organigram Holdings Inc. 6-K
21 Mar 23
6-K
Organigram Holdings Inc. 6-K
14 Mar 23
Transcripts
OGI
Earnings call transcript
2022 Q4
29 Nov 22
OGI
Earnings call transcript
2022 Q3
14 Jul 22
OGI
Earnings call transcript
2022 Q2
12 Apr 22
OGI
Earnings call transcript
2022 Q1
11 Jan 22
OGI
Earnings call transcript
2021 Q4
23 Nov 21
OGI
Earnings call transcript
2021 Q3
13 Jul 21
OGI
Earnings call transcript
2021 Q2
13 Apr 21
OGI
Earnings call transcript
2021 Q1
12 Jan 21
OGI
Earnings call transcript
2020 Q4
30 Nov 20
Latest ownership filings
SC 13D/A
BT DE Investments Inc.
1 Feb 22
SC 13G/A
ETF MANAGERS GROUP, LLC
16 Nov 21
SC 13G/A
ETF MANAGERS GROUP, LLC
16 Aug 21
SC 13D
BT DE Investments Inc.
19 Mar 21
SC 13G/A
ETF MANAGERS GROUP, LLC
16 Feb 21
SC 13G/A
ETF MANAGERS GROUP, LLC
11 Dec 20
SC 13G/A
ETF MANAGERS GROUP, LLC
16 Nov 20
SC 13G/A
ETF MANAGERS GROUP, LLC
14 Oct 20
SC 13G/A
ETF MANAGERS GROUP, LLC
1 Sep 20
SC 13G/A
ETF MANAGERS GROUP, LLC
20 Aug 20
Financial summary
| Quarter (USD) | Aug 22 | Aug 21 | Aug 20 | Aug 19 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Aug 22 | Aug 21 | Aug 20 | Aug 19 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
Institutional ownership, Q4 2022
24.2% owned by funds/institutions
| 13F holders | Current |
|---|---|
| Total holders | 119 |
| Opened positions | 20 |
| Closed positions | 17 |
| Increased positions | 23 |
| Reduced positions | 28 |
| 13F shares | Current |
|---|---|
| Total value | 14.90 bn |
| Total shares | 77.96 mm |
| Total puts | 274.40 k |
| Total calls | 1.36 mm |
| Total put/call ratio | 0.2 |
| Largest owners | Shares | Value |
|---|---|---|
| BT DE Investments | 58.34 mm | $99.76 mm |
| Mirae Asset Global Investments | 2.53 mm | $2.05 bn |
| D. E. Shaw & Co. | 2.03 mm | $1.65 bn |
| BMO Bank of Montreal | 1.87 mm | $1.52 bn |
| Merlin Capital | 1.52 mm | $1.22 bn |
| Intact Investment Management | 1.31 mm | $1.06 bn |
| AdvisorShares Investments | 1.21 mm | $969.35 mm |
| Renaissance Technologies | 1.11 mm | $892.58 mm |
| Dimensional Fund Advisors | 983.65 k | $787.00 k |
| Susquehanna International | 674.49 k | $539.59 mm |
News
Organigram Invests In Phylos Bioscience To Commercialize THCV And Scale Seed Based Production
26 May 23
Stocks That Hit 52-Week Lows On Thursday
25 May 23
Marijuana Stock Movers For May 24, 2023
24 May 23
Cannabis Stock Gainers And Losers From May 23, 2023
23 May 23
Organigram To Enter German Cannabis Market Via Sanity Group
23 May 23
Press releases
Organigram Makes First Strategic U.S. Investment in Phylos Bioscience to Commercialize THCV and Scale Seed Based Production
25 May 23
Organigram to Enter German Market Supplying Sanity Group
23 May 23
Organigram Announces Achievement of Earnout by The Edibles and Infusions Corporation
19 May 23
Organigram Reports Second Quarter Fiscal 2023 Results
11 Apr 23
Organigram to Report Second Quarter Fiscal 2023 Results on April 11, 2023
4 Apr 23